AZ will invest £300m in UK, says PM Keir Starmer
AstraZeneca has delivered a much-needed boost to the UK government alongside a strong set of first-quarter results.
Newsletters and Deep Dive digital magazine
AstraZeneca has delivered a much-needed boost to the UK government alongside a strong set of first-quarter results.
The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.
A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.
With the ink barely dry on a deal to buy Kelonia, Lilly has signed a $2.3bn deal to acquire Ajax Therapeutics and its JAK2 blood cancer therapy.
A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over cancer drug Jemperli.
Editor's Picks
Newsletters and Deep Dive
digital magazine